retatrutide phase 3 results New data dropped and everyone's running with the big number. 30% body weight loss at 12mg. Impressive headline. But nobody's talking about 4mg. 📊 19% body weight loss 📊 Eli Lilly's Phase 3 data

Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition

Good candidates for peptides for weight loss generally include people who have: A body mass index (BMI) of 30 or higher A BMI of 27 or higher paired with a weight-related health condition, such as high blood pressure, high cholesterol, or diabetes Ongoing struggles with stubborn belly fat or a slow metabolism Age-related fat gain, particularly common among men in their 30s, 40s, 50s, and beyond A weight-loss plateau despite staying consistent with exercise and a clean diet Weight gain linked to a hormonal imbalance or low testosterone Peptide therapy is not appropriate for everyone, however

Transitioning off GLP-1 without a strategy can feel overwhelming food noise returns, cravings reappear, and old dieting habits can resurface

[PubMed: 8967667] Review Pediatric Implications of Normal Insulin-GH-IGF Axis Physiology.[Endotext